|
C14ORF104 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.87340000074232E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33840000030128E-07 |
| Normal-vs-Stage2 |
7.95789999999963E-05 |
| Normal-vs-Stage3 |
1.143690E-03 |
| Normal-vs-Stage4 |
1.613750E-02 |
| Stage1-vs-Stage2 |
7.706200E-01 |
| Stage1-vs-Stage3 |
8.417200E-01 |
| Stage1-vs-Stage4 |
7.037600E-01 |
| Stage2-vs-Stage3 |
6.539600E-01 |
| Stage2-vs-Stage4 |
8.629000E-01 |
| Stage3-vs-Stage4 |
6.149400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.44029998617424E-09 |
| Normal-vs-AfricanAmerican |
5.568700E-04 |
| Normal-vs-Asian |
3.560800E-01 |
| Caucasian-vs-AfricanAmerican |
1.747440E-01 |
| Caucasian-vs-Asian |
5.377600E-01 |
| AfricanAmerican-vs-Asian |
8.958000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87299999954149E-08 |
| Normal-vs-Female |
1.372450E-04 |
| Male-vs-Female |
3.295000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.572350E-04 |
| Normal-vs-Extreme_Weight |
7.27029999536555E-08 |
| Normal-vs-Obese |
2.235500E-04 |
| Normal-vs-Extreme_Obese |
3.246000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.088600E-01 |
| Normal_Weight-vs-Obese |
3.813400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.120800E-01 |
| Extreme_Weight-vs-Obese |
1.657160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.548600E-01 |
| Obese-vs-Extreme_Obese |
6.542600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.665600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.59070000000017E-05 |
| Normal-vs-Age(61-80Yrs) |
5.55830004245195E-09 |
| Normal-vs-Age(81-100Yrs) |
1.07490000011978E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.596800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.024300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.904400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.330300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.538220E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.378380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.6967999999794E-06 |
| Normal-VS-Type2 PRCC |
6.12860000526183E-08 |
| Normal-VS-KIRP CIMP |
3.215400E-04 |
| Normal-VS-Unclassified PRCC |
4.02870000000277E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.231700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.977400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.535020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.776000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.565400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.951400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.46020001329839E-09 |
| Normal-vs-N1 |
4.524400E-03 |
| Normal-vs-N2 |
3.72169999995897E-06 |
| N0-vs-N1 |
7.458400E-02 |
| N0-vs-N2 |
1.390980E-01 |
| N1-vs-N2 |
3.009900E-02 |
|
|
